A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Feature|Articles|April 7, 2026
ACIP Changes Disrupt Vaccine Coverage Pipeline, Raise Cost Concerns
Author(s)Giuliana Grossi
Fact checked by: Christina Mattina
ACIP changes threaten vaccine coverage and raise costs, according to a roundtable of experts warning of widening disparities and long-term public health risks.
Advertisement
Advertisement
For decades, the CDC Advisory Committee on Immunization Practices (ACIP) served as the linchpin of pediatric vaccine policy, and by extension, the basis on which insurers determined what they would cover. When ACIP recommended a vaccine, coverage followed. That equation is now broken, and the financial fallout will be felt most acutely by families least equipped to absorb it, according to a panel of experts.
Related to this article
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
CMS finalized Transparency in Coverage updates as a researcher warns ghost rates and missing inpatient data limit payer price files.
Amanda Velazquez, MD, discusses GLP-1 formulary strategies, overcoming prior authorization hurdles, and building scalable obesity care infrastructure.
Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.
Even when physicians prescribe guideline-preferred therapies, step therapy and prior authorization can delay or restrict access to CLL therapies.
The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
The trade group says CMS lacks authority to impose GLOBE, which is set to begin January 1.
Advertisement
Advertisement